Navigation Links
Yashoda Cancer Institute Treats First Patient in India Using RapidArc Radiotherapy Technology
Date:4/20/2009

HYDERABAD, India, April 20 /PRNewswire/ -- Clinicians in India have carried out the country's first treatment using a new, faster form of radiotherapy that extends more advanced care to more patients. A 72-year-old bladder cancer patient received the pioneering treatment using RapidArc radiotherapy technology from Varian Medical Systems (NYSE: VAR) at Yashoda Cancer Institute in Hyderabad.

Varian's RapidArc technology makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT. RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and offers several advantages over traditional approaches, according to clinician Dr. Srinivas Chilikuri.

"The whole treatment duration including set-up and check was completed in ten minutes, which involved just 90 seconds of 'beam-on' time," said Dr. Chilikuri. "We witnessed high dose conformity, excellent target coverage and good critical tissue sparing but the main advantage was the speed of the treatment."

Dr. Chilikuri said speed is particularly important because of the large number of cancer patients in India. "In a country like ours with a heavy cancer burden there is a real issue with waiting lists," he said. "We deal with this by prioritising and optimizing treatment facilities and RapidArc is an excellent example of this approach. With this, we can carry out faster and more precise treatments with less complex delivery and less complicated quality assurance requirements.

"The whole point of acquiring RapidArc was to treat more and more patients with high precision technology. With RapidArc's fast and efficient treatment delivery we will significantly increase the number of patients treated with advanced conformal techniques."

Dr. Chilikuri said the clinical team at Yashoda plans to use RapidArc for a variety of common cancers such as head & neck, cervical, prostate and lung, as well as complicated tumors which are otherwise difficult to treat with other techniques.

Yashoda Cancer Institute is an international quality 200 bed comprehensive cancer research and treatment center operated by Yashoda Hospitals. The cancer institute provides healthcare to 7,000 cancer patients every year. A comprehensive cancer center with state-of-the-art technology, the hospital treats patients from south and east India, South Asia and the Middle East. Dheeraj Gorukanti, chief executive officer of Yashoda Hospitals Group, said, "Yashoda Hospitals is proud to be one of the first sites in the world to implement Varian's RapidArc system. We believe it will provide a real edge in helping patients fight cancer."

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... How physicians and athletic trainers assess ... researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s ... the patterns of change in concussion symptom presentation, diagnostic tools used and length ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital stays or who ... in such facilities are specially designed to accommodate patients with a wide range of ... inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, a specially designed ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network of ... Chiropractic , directed by Dr. Russell Horine, DC to their exclusive list of medical ... Dr. Russell Horine serving as the clinic director and his son Dr. Lee Horine ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... **An FDAnews Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... passing inspections and boosting quality. , It’s known as the “CY2016 Annual FDA ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... -- Endo International plc (NASDAQ: ENDP ) today ... manufacturing network, the Company will be ceasing operations and ... Huntsville, Alabama . The closure of the facilities ... to 18 months. The Huntsville ... products and these restructuring actions are intended to better ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/17/2017)... -- MedX Holdings, Inc., the manufacturer and global distributor of ... today announced the national roll out of its MedX ... standard for the treatment of low back injuries and ... How it works: MedX ... who prescribe the MedX Home Back Machine Program for ...
Breaking Medicine Technology: